PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Clinical trials for PSP - PROGRESSIVE SUPRANUCLEAR PALSY explained in plain language.
Never miss a new study
Get alerted when new PSP - PROGRESSIVE SUPRANUCLEAR PALSY trials appear
Sign up with your email to follow new studies for PSP - PROGRESSIVE SUPRANUCLEAR PALSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for PSP: experimental vaccine-like drug enters key trial
Disease control Not yet recruitingThis study tests whether AADvac1 can slow down progressive supranuclear palsy (PSP), a rare brain disease that affects movement, balance, and thinking. About 146 people with early-to-moderate PSP will receive the drug or a placebo. The main goal is to see if the drug reduces dise…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 26, 2026 04:32 UTC
-
Hope on the horizon: new drug trial aims to slow rare brain disease PSP
Disease control Not yet recruitingThis Phase 2 trial tests whether the drug LM11A-31 can slow the progression of Progressive Supranuclear Palsy (PSP), a rare brain disease that affects movement and thinking. About 147 people with early-stage PSP will receive the drug or a placebo. The study measures changes in sy…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 18, 2026 12:02 UTC